Jeffrey Kaine
Rheumatology · Sarasota, FLNPI 1154308427
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $197,748 of the $273,585 with a category attached, or 72.3%. 10 manufacturers reported payments, led by Sanofi at 58.2% of the total. Among rheumatology clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 227 payments — averaging $1205.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$159K
- Lilly USA, LLC$63K
- Regeneron Healthcare Solutions, Inc.$13K
- Pfizer$13K
- Merck$12K
- Gilead$6K
- plus $7K from 4 others
Across 11 payments — averaging $2359.95 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novartis$9K
- E.r. Squibb & Sons, L.L.C.$7K
- Amgen$5K
- AbbVie$4K
- Sanofi$893
- Sanofi-aventis U.S. LLC$353
What the payments were for
- Consulting fees$197,74872%
- Speaking & faculty fees$49,95718%
- Travel & lodging$22,7968%
- Food & beverage$2,9931%
- Education$910%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 23 | $159,090 |
| Lilly USA, LLC | 117 | $63,039 |
| Regeneron Healthcare Solutions, Inc. | 29 | $13,259 |
| Pfizer | 9 | $13,077 |
| Merck | 15 | $11,683 |
| Gilead | 16 | $6,134 |
| AbbVie | 13 | $4,998 |
| CSL Behring | 1 | $2,168 |
| UCB, Inc. | 3 | $99 |
| GSK | 1 | $40 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$273,585 in reported general payments places this provider in the 90th percentile of 453 rheumatology providers in Florida.
Other rheumatology in Sarasota
- Alvin WellsDestin$2.4M
- Guillermo ValenzuelaPlantation$1.5M
- Julio Gonzalez-PaoliTampa$1.4M
- Ernesto RodriguezZephyrhills$958K
- Vinicius Costa Diniz DominguesDaytona Beach$921K
- Jonathan GreerBoynton Beach$757K
- Jigar ShahMargate$750K
- Rachel TateHollywood$729K
- Howard BuschLoxahatchee$717K
- Michael WeitzMiami$658K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.